{"gene":"HCST","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1999,"finding":"DAP10 (HCST/KAP10) was identified as a transmembrane adaptor protein that forms an activating immunoreceptor complex with NKG2D on NK and T cells, recognizing the stress-inducible MHC molecule MICA. The cytoplasmic YINM (YxxM) motif of DAP10 recruits the p85 subunit of PI3-kinase, providing NKG2D-dependent signal transduction.","method":"Co-immunoprecipitation, transfection/expression studies, PI3K recruitment assay, cell surface expression analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 — original discovery with biochemical reconstitution of complex, PI3K binding demonstrated, replicated across multiple subsequent studies","pmids":["10426994"],"is_preprint":false},{"year":1999,"finding":"DAP10 (KAP10) is genetically linked to DAP12 on human chromosome 19 and, unlike ITAM-containing adaptors, signals via phosphorylation of its cytoplasmic YINM motif to activate PI3K and downstream Akt, rather than recruiting Syk-family kinases. DAP10 can also bind the adaptor protein Grb2.","method":"Molecular cloning, sequence analysis, transfection, PI3K/Akt activation assays, Grb2 binding assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1–2 — original cloning with functional characterization of signaling motif, replicated in subsequent studies","pmids":["10528161"],"is_preprint":false},{"year":2000,"finding":"Despite high similarity between DAP10 and DAP12, their transmembrane regions are sufficient to confer specific association with distinct ligand-binding receptor partners. DAP10 signals via the PI3K pathway (YxNM motif), while DAP12 signals via Syk/ZAP70 through its ITAM motif. Cross-linking of either DAP10- or DAP12-associated receptors alone can trigger NK cytotoxicity, but synergy occurs in cytokine production when both are co-engaged.","method":"Transfection with transmembrane domain swap mutants, NK cell cytotoxicity assays, cytokine production assays, co-immunoprecipitation","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — reciprocal domain-swap experiments with functional readouts, replicated across labs","pmids":["11015446"],"is_preprint":false},{"year":2001,"finding":"Pig DAP10 contains conserved structural features including an aspartic acid in the transmembrane domain, two cysteines in the extracellular domain, and a PI3K-binding YxxM motif in the cytoplasmic region. Pig NKG2D requires DAP10 for cell surface expression when transiently transfected into COS-7 cells, demonstrating the conserved requirement for DAP10 in NKG2D surface trafficking.","method":"cDNA cloning, sequence analysis, transient transfection in COS-7 cells, cell surface expression by flow cytometry","journal":"Immunogenetics","confidence":"Medium","confidence_rationale":"Tier 2 — single lab, functional demonstration of DAP10-dependent NKG2D surface expression in heterologous cells","pmids":["11398969"],"is_preprint":false},{"year":2003,"finding":"A critical YINM amino acid motif in the DAP10 cytoplasmic tail couples NKG2D receptor stimulation to activation of PI3K, Vav1, Rho family GTPases, and phospholipase C, triggering NK cell killing independently of Syk family tyrosine kinases. This defines a Syk-independent activation pathway for ITAM-lacking receptor complexes.","method":"Mutational analysis of DAP10 cytoplasmic YINM motif, NK cell killing assays, signaling pathway analysis (PI3K, Vav1, Rho GTPase, PLC activation), Syk kinase inhibition","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis of key motif combined with multiple orthogonal signaling assays and functional cytotoxicity readout","pmids":["12740575"],"is_preprint":false},{"year":2003,"finding":"SIRPβ1 can associate with DAP10 in transfected RBL-2H3 cells, but engagement of SIRPβ1–DAP10 complexes alone does not trigger serotonin release or TNF secretion; instead, DAP10 provides co-stimulatory activity that enhances FcεRI-mediated effector functions under sub-optimal stimulation conditions, demonstrating that DAP10's signaling output is context-dependent.","method":"Transfection of RBL-2H3 cells, co-immunoprecipitation, serotonin release assay, TNF secretion assay, FcεRI co-stimulation assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in a defined cell model, single lab","pmids":["14635062"],"is_preprint":false},{"year":2004,"finding":"Using mice lacking one, two, or all three Vav family proteins, Vav1 deficiency alone is sufficient to disrupt DAP10-mediated NK cell cytotoxicity, whereas Vav2 and Vav3 are preferentially required for FcRγ- and DAP12-mediated cytotoxicity. This places Vav1 specifically downstream of DAP10 in NK cell activation.","method":"Genetic epistasis using Vav1/2/3 single, double, and triple knockout mice; NK cell cytotoxicity assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1–2 — clean genetic epistasis with multiple knockout combinations and defined functional readout","pmids":["15365099"],"is_preprint":false},{"year":2005,"finding":"Stable RNA interference-mediated silencing of DAP10 (and NKG2D or DAP12) in human CD8+ T cells and NK cells reduces cytolysis of tumor cells including autologous ovarian cancer cells, and abolishes in vivo antitumor activity, demonstrating that DAP10 is required for effector cell function.","method":"Lentiviral stable shRNA knockdown, in vitro tumor cytolysis assays, in vivo antitumor model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — stable KD with both in vitro and in vivo functional readouts, multiple target genes confirmed","pmids":["16339517"],"is_preprint":false},{"year":2006,"finding":"For NKG2D-DAP10-mediated cytotoxicity, both Grb2–Vav1 binding and p85 PI3K binding to the DAP10 YINM motif are required. Grb2–Vav1 binding to DAP10 is sufficient to initiate tyrosine phosphorylation events, but full calcium release and cytotoxicity require the simultaneous recruitment of both Grb2–Vav1 and p85 to the same DAP10 motif.","method":"Dominant-negative constructs, point mutations of DAP10 YINM motif, co-immunoprecipitation, calcium flux assays, NK cell cytotoxicity assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis combined with multiple orthogonal assays (Co-IP, calcium, cytotoxicity), strong mechanistic resolution","pmids":["16582911"],"is_preprint":false},{"year":2006,"finding":"Vav1 is a critical signaling mediator downstream of DAP10 in NK cells, required for DAP10-induced cytoskeletal polarization involving both actin and microtubule networks, maturation of the cytolytic synapse, and target cell lysis. Vav1 interacts with DAP10 YINM motifs through the adaptor Grb2 and is required for activation of PI3K-dependent Akt signaling downstream of DAP10.","method":"Vav1/DAP12 double-knockout mice, NK cell cytoskeletal polarization assays (imaging), synapse maturation analysis, cytotoxicity assays, Co-IP of Vav1–Grb2–DAP10","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic model combined with imaging and biochemical assays, multiple orthogonal methods","pmids":["16887996"],"is_preprint":false},{"year":2006,"finding":"IL-21 down-regulates NKG2D–DAP10 surface expression on human NK and CD8+ T cells by markedly reducing DAP10 transcription, as demonstrated by reduced DAP10 promoter activity in a luciferase reporter assay. This functional loss of DAP10 correlates with impaired NKG2D-mediated NK cell cytotoxicity and degranulation.","method":"Primary NK/CD8+ T cell culture with cytokines, flow cytometry, DAP10 luciferase reporter assay, redirected lysis assay, degranulation assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — promoter reporter assay directly demonstrates transcriptional mechanism, corroborated with functional readouts","pmids":["16424177"],"is_preprint":false},{"year":2007,"finding":"DAP10-deficient mice develop osteopetrosis with age due to reduced osteoclast numbers, revealing a physiological role for DAP10 in bone remodeling. DAP10 deficiency also results in hyperactive NKT cell functions and impaired regulatory T cell (Treg) activation, showing that constitutive DAP10 signaling regulates immune tolerance by adjusting the activation threshold of NKT cells and Tregs.","method":"DAP10 knockout mouse analysis, bone histology, NK/NKT cell functional assays (cytotoxicity, cytokine), Treg activation assays (IL-2, IL-10, IFN-γ production)","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with multiple cellular phenotype readouts, single lab","pmids":["17785813"],"is_preprint":false},{"year":2008,"finding":"LGLL cells express elevated DAP10 and DAP12 with constitutively activated downstream targets. Expression of dominant-negative DAP10 dramatically reduces the lytic capacity of LGLL CD8+CD28null T cells against pulmonary artery endothelial and synovial cells, demonstrating that DAP10 signaling is required for enhanced cytotoxicity in this leukemia.","method":"Dominant-negative DAP10 expression, cytotoxicity assays against endothelial and synovial target cells, western blot for constitutive downstream signaling","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — dominant-negative functional experiment with specific cellular phenotype, single lab","pmids":["19075187"],"is_preprint":false},{"year":2009,"finding":"DAP10 associates with the myeloid receptor MDL-1, which also associates with DAP12. In osteoclasts and bone marrow-derived macrophages, MDL-1 forms trimolecular complexes with both DAP12 and DAP10 (ITAM/YINM motifs), and DAP10 association with MDL-1 depends almost entirely on DAP12, suggesting DAP12-dependent recruitment of DAP10 into the complex. DAP10-deficient mice become osteopetrotic, confirming DAP10's role in osteoclastogenesis.","method":"Co-immunoprecipitation of MDL-1–DAP12–DAP10 complexes, DAP10 knockout mouse bone phenotype analysis, in vitro osteoclastogenesis assay","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP identifying trimolecular complex, corroborated with KO mouse phenotype and in vitro functional assay","pmids":["19251634"],"is_preprint":false},{"year":2009,"finding":"During NK cell activation, exposure to MICB-expressing target cells causes lysosomal degradation of DAP10, with approximately 50% of total NKG2D protein degraded. DAP10 traffics to secretory lysosomes in activated NK cells upon interaction with MICB-expressing targets, and polarization of DAP10-containing secretory lysosomes to the cytotoxic immune synapse is observed, suggesting that rapid DAP10/NKG2D degradation upon synapse formation explains receptor down-regulation after chronic ligand exposure.","method":"Confocal microscopy, lysosomal inhibitor treatment, subcellular fractionation, flow cytometry for NKG2D surface expression kinetics in NKL cells and primary NK cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct live-cell imaging and fractionation experiments linking DAP10 trafficking to functional consequence","pmids":["19329438"],"is_preprint":false},{"year":2009,"finding":"Ly49H must associate with and signal via both DAP10 and DAP12 for optimal NK cell function during MCMV infection. In the absence of DAP12, DAP10 enables Ly49H-mediated target cell killing and proliferation. DAP10-deficient Ly49H+ NK cells show diminished ERK1/2 activation, reduced IFN-γ production, and impaired control of MCMV infection, demonstrating that DAP10 contributes distinct signaling outputs (ERK activation, cytokine production) to the Ly49H receptor complex.","method":"DAP10 and DAP12 single/double knockout mice, MCMV infection model, NK cell cytotoxicity assays, proliferation assays, ERK1/2 phosphorylation, IFN-γ production, viral titer measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — clean genetic models with multiple orthogonal functional and signaling readouts in vivo","pmids":["19332875"],"is_preprint":false},{"year":2009,"finding":"DAP10 associates with Ly49H and Ly49D in primary mouse NK cells, slightly contributing to their cell surface expression, but this association has no significant impact on Ly49H-mediated control of MCMV infection in physiological conditions, indicating that functional consequences of DAP10 association vary widely among activating NK receptors.","method":"Co-immunoprecipitation from primary NK cells, flow cytometry for receptor surface expression, MCMV infection model in DAP10-deficient mice","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP from primary cells with in vivo functional test, single lab","pmids":["19247984"],"is_preprint":false},{"year":2010,"finding":"TREM2/DAP12-dependent activation of PI3K requires DAP10 as a co-signaling adaptor. Ligation of TREM2 activates PI3K, ERK1/2, and Vav3; induces Ca2+ mobilization and actin reorganization; and prevents apoptosis. DAP10 is essential for recruitment of PI3K to the TREM2–DAP12 signaling complex. SHIP1 inhibits this pathway by binding DAP12 via its SH2 domain, preventing PI3K recruitment to DAP12.","method":"TREM2 ligation assays, PI3K recruitment assays, ERK/Vav3/Ca2+ activation assays, actin reorganization microscopy, DAP10-deficient cells, SHIP1 SH2 domain mutant experiments, co-immunoprecipitation","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal signaling assays, domain mutants, genetic DAP10-deficiency model, replicated across several readouts","pmids":["20484116"],"is_preprint":false},{"year":2010,"finding":"DAP10 contributes to CD8+ T cell-mediated cytotoxicity during Mycobacterium tuberculosis infection. DAP10-deficient mice show significantly reduced CD8 T cell-mediated cytotoxicity during Mtb infection, associated with impaired cytotoxic granule release, without affecting CD8 T cell recruitment, activation, or IFN-γ production frequency.","method":"DAP10 knockout mouse aerosol Mtb infection model, CD8 T cell cytotoxicity assays, granule release assay, flow cytometry for T cell activation markers and IFN-γ","journal":"Immunobiology","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic KO with specific cytolytic phenotype in infection model, single lab","pmids":["21122940"],"is_preprint":false},{"year":2011,"finding":"IL-2 and γc cytokines up-regulate DAP10 expression primarily at the posttranscriptional level, increasing DAP10 protein synthesis. Newly synthesized DAP10 undergoes glycosylation that is required for its association with NKG2D and stabilization of NKG2D surface expression. TGF-β1 exerts an opposing dominant effect by inhibiting RNA polymerase II association with the DAP10 promoter, decreasing DAP10 mRNA, which causes secondary loss of NKG2D protein.","method":"NK cell cytokine stimulation, qRT-PCR, immunoblotting, chromatin immunoprecipitation (RNA Pol II at DAP10 promoter), co-immunoprecipitation of DAP10–NKG2D, glycosylation inhibitor treatment","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP demonstrates transcriptional mechanism, glycosylation experiments link PTM to NKG2D association, multiple orthogonal approaches","pmids":["21816829"],"is_preprint":false},{"year":2011,"finding":"In rodents (rat and mouse), DAP10 and DAP12 associate not with NKG2C/E but with CD94, via a transmembrane lysine residue unique to rodent CD94. This represents a phylogenetic transfer of adaptor-binding capacity from NKG2C/E to the CD94 chain, demonstrating that DAP10 association with NK receptor complexes is mediated by specific transmembrane charged residue interactions.","method":"Transfection with NKG2C mutant constructs, flow cytometry, biochemical co-immunoprecipitation from primary rat NK cells, redirected lysis assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical Co-IP and mutational analysis, single lab, functional validation","pmids":["22084441"],"is_preprint":false},{"year":2012,"finding":"TGF-β1 down-regulates both DAP10 and NKG2D surface expression on NK cells from HBV-infected patients, impairing NK cell cytotoxicity and IFN-γ production. In vitro, TGF-β1 treatment recapitulates this down-regulation, and anti-TGF-β1 antibodies restore NKG2D and DAP10 expression, placing TGF-β1 as a key negative regulator of the NKG2D–DAP10 pathway during chronic viral infection.","method":"Flow cytometry of NK cells from HBV patients and healthy controls, in vitro TGF-β1 treatment, anti-TGF-β1 antibody restoration experiments, NK cell cytotoxicity and IFN-γ assays","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2–3 — antibody rescue experiment supports mechanism, but primarily patient sample data with limited mechanistic depth","pmids":["22438812"],"is_preprint":false},{"year":2014,"finding":"DAP10 associates with the receptor for advanced glycation end products (RAGE) in human keratinocytes. RAGE–DAP10 heterodimer formation markedly enhances Akt activation (pro-survival signaling), whereas homomultimeric RAGE interaction leads to caspase-8 activation and apoptosis. Functional blocking of DAP10 in transformed keratinocyte lines abrogates Akt phosphorylation from S100A8/A9-activated RAGE, leading to increased apoptosis.","method":"Artificial oligomerization assay, co-immunoprecipitation of RAGE–DAP10, Akt phosphorylation assay, caspase-8 activation assay, DAP10 functional blocking antibody, DAP10-overexpressing cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — novel binding partner identified with functional consequences using multiple assays, single lab","pmids":["25002577"],"is_preprint":false},{"year":2015,"finding":"Ligand-induced endocytosis of NKG2D–DAP10 complexes in human NK cells depends on ubiquitylation of DAP10. This ubiquitin-dependent endocytosis is required not only for degradation of internalized receptor complexes but also for activation of ERK and NK cell effector functions including cytotoxic granule secretion and IFN-γ production, demonstrating that endosomal DAP10 signaling is functionally critical.","method":"Biochemical ubiquitylation assays, dominant-negative ubiquitin constructs, confocal microscopy of receptor endocytosis, ERK activation assays, cytotoxic granule secretion assay, IFN-γ production assay in human NK cells","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1–2 — ubiquitylation biochemistry combined with dominant-negative functional experiments and multiple effector function readouts","pmids":["26508790"],"is_preprint":false},{"year":2019,"finding":"EVL (Ena/VASP-like), an actin regulatory protein, is recruited to the NK cell cytotoxic synapse via NKG2D–DAP10 signaling, through the same binding site on DAP10 previously implicated in Vav1 and Grb2 recruitment. EVL interacts with WASP and VASP and is required for F-actin generation at the synapse, NK cell–target cell adhesion, and cytotoxicity.","method":"Co-immunoprecipitation of EVL with DAP10/Grb2/Vav1, confocal microscopy of synapse recruitment, siRNA knockdown of EVL, F-actin quantification at synapse, NK cell adhesion and cytotoxicity assays","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — Co-IP identifies novel binding partner at known DAP10 site, KD with multiple orthogonal functional and imaging readouts","pmids":["31235500"],"is_preprint":false},{"year":2021,"finding":"CD33 (Siglec-3) preferentially inhibits NKG2D/DAP10-mediated NK cell cytotoxicity. CD33-mediated inhibition of NKG2D-triggered cytotoxicity involves dephosphorylation of Vav1, placing Vav1 as a convergence point between the DAP10 activating pathway and CD33 inhibitory signaling.","method":"NK cell and NKL cell cytotoxicity assays with CD33 co-engagement, phospho-Vav1 western blot, comparison with ILT-2/CD94-NKG2A inhibitory receptors","journal":"Journal of immunology research","confidence":"Medium","confidence_rationale":"Tier 2–3 — phospho-signaling readout with functional cytotoxicity data, single lab","pmids":["31143782"],"is_preprint":false},{"year":2021,"finding":"CD200AR-L/CD200AR binding signals through DAP10 (not DAP12) to control anti-glioma tumor immunity in vivo. The CD200AR–DAP10 pathway shows initial activation followed by transient decrease and reactivation via a positive feedback loop. In vivo studies using DAP10/DAP12 knockout mice confirm that DAP10, but not DAP12, is required for tumor control by this immune checkpoint receptor pathway.","method":"Transcription, protein, and phosphorylation analysis in vitro; DAP10/DAP12 double-KO mouse glioma model; pharmacological inhibitor studies; intracranial GBM model survival assay","journal":"Neurotherapeutics","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO model confirms DAP10-specificity in vivo, with in vitro signaling characterization","pmids":["33829411"],"is_preprint":false},{"year":2025,"finding":"ACLY-deficient NK cells show decreased DAP12 and increased DAP10 transcript and protein levels. Epigenetic profiling demonstrates altered histone acetylation at the DAP10 and DAP12 gene loci in ACLY KO cells. Acetate supplementation restores DAP10/DAP12 expression and activating receptor function, demonstrating that cytosolic acetyl-CoA generated by ACLY controls DAP10 and DAP12 expression through histone acetylation.","method":"Inducible ACLY knockout mouse model, RNA-seq, western blot, epigenetic/histone acetylation profiling (ChIP), acetate supplementation rescue, NK cell functional assays (cytotoxicity, cytokine)","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with epigenetic profiling and rescue experiment; preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.03.05.639198"],"is_preprint":true}],"current_model":"HCST (DAP10) is a transmembrane adaptor protein that forms activating immunoreceptor complexes with NKG2D (and other receptors including MDL-1, RAGE, and Ly49H) on NK and T cells; its cytoplasmic YINM motif recruits both the p85 subunit of PI3K and a Grb2–Vav1 intermediate simultaneously—both interactions being required for full downstream signaling including PI3K/Akt activation, Vav1-mediated cytoskeletal polarization (actin and microtubule networks), ERK activation, calcium flux, and cytotoxic granule secretion; ligand-induced DAP10 ubiquitylation drives endocytosis required for ERK signaling and effector functions, while DAP10 surface expression is regulated transcriptionally (by TGF-β1 via RNA Pol II exclusion from the DAP10 promoter, and by IL-21 via promoter repression) and post-transcriptionally (by γc cytokines promoting DAP10 synthesis and glycosylation, the latter being required for NKG2D association and stabilization)."},"narrative":{"teleology":[{"year":1999,"claim":"Identification of DAP10 as a transmembrane adaptor that pairs with NKG2D and recruits PI3K via its YINM motif established the first non-ITAM activation mechanism for NK receptors, answering how NKG2D signals without Syk-family kinases.","evidence":"Co-immunoprecipitation, transfection, and PI3K recruitment assays in NK/T cell lines; independent cloning and Grb2 binding demonstration","pmids":["10426994","10528161"],"confidence":"High","gaps":["Relative contributions of PI3K vs. Grb2 recruitment unresolved","In vivo requirement not yet tested"]},{"year":2000,"claim":"Transmembrane domain swap experiments demonstrated that DAP10 and DAP12 achieve receptor specificity through their transmembrane regions and activate distinct signaling pathways (PI3K vs. ITAM/Syk), resolving how structurally similar adaptors partition among activating receptors.","evidence":"TM domain chimeras with NK cytotoxicity and cytokine assays","pmids":["11015446"],"confidence":"High","gaps":["Structural basis of TM-mediated specificity undefined","Stoichiometry of receptor–adaptor complexes unknown"]},{"year":2003,"claim":"Mutational dissection of the YINM motif showed it couples NKG2D to PI3K, Vav1, Rho GTPases, and PLC independently of Syk kinases, defining the complete proximal signaling module downstream of DAP10.","evidence":"YINM point mutations with NK killing assays and multi-pathway signaling analysis","pmids":["12740575"],"confidence":"High","gaps":["Whether both PI3K and Grb2 branches are co-required or redundant was unresolved","Kinase(s) phosphorylating YINM not identified"]},{"year":2006,"claim":"Simultaneous binding of both Grb2–Vav1 and p85-PI3K to the same DAP10 YINM motif was shown to be required for full calcium flux and cytotoxicity, resolving the non-redundancy of the two signaling arms and establishing Vav1 as the specific Vav family member mediating DAP10-dependent cytoskeletal polarization and synapse maturation.","evidence":"Dominant-negative constructs and YINM point mutations with calcium, Co-IP, and cytotoxicity assays; Vav1/2/3 single and combinatorial KO mice with NK killing assays and cytoskeletal imaging","pmids":["16582911","15365099","16887996"],"confidence":"High","gaps":["Structural basis for simultaneous Grb2 and p85 occupancy of one motif unclear","How Vav1 specificity over Vav2/3 is achieved molecularly not defined"]},{"year":2009,"claim":"DAP10 was found to extend beyond NKG2D pairing to form signaling complexes with MDL-1 (via DAP12-dependent recruitment) and Ly49H, and DAP10-deficient mice developed osteopetrosis, broadening DAP10's biological role to osteoclastogenesis and antiviral NK responses.","evidence":"Reciprocal Co-IP of MDL-1–DAP12–DAP10 trimolecular complex; DAP10 KO mouse bone histology and osteoclast assays; DAP10/DAP12 single/double KO MCMV infection model with ERK, IFN-γ, and viral titer readouts","pmids":["19251634","19332875","17785813"],"confidence":"High","gaps":["Whether DAP10 signals autonomously or only through DAP12-containing complexes with MDL-1 not clarified","Functional significance of DAP10–Ly49D association disputed between labs"]},{"year":2011,"claim":"The opposing transcriptional regulation of DAP10 was elucidated: TGF-β1 excludes RNA Pol II from the DAP10 promoter to suppress expression, while γc cytokines promote post-transcriptional DAP10 synthesis and glycosylation required for NKG2D association, explaining how the tumor/infection microenvironment tunes NKG2D–DAP10 surface levels.","evidence":"ChIP for RNA Pol II at DAP10 promoter with TGF-β1 treatment; glycosylation inhibitor experiments showing loss of NKG2D–DAP10 co-IP; IL-21 promoter reporter assay","pmids":["21816829","16424177"],"confidence":"High","gaps":["Transcription factors mediating TGF-β1's exclusion of Pol II not identified","Specific glycosylation sites on DAP10 required for NKG2D binding unknown"]},{"year":2014,"claim":"Discovery that DAP10 pairs with RAGE in keratinocytes to switch RAGE signaling from apoptotic (caspase-8) to pro-survival (Akt) extended DAP10 function beyond hematopoietic cells.","evidence":"Co-IP of RAGE–DAP10, Akt phosphorylation and caspase-8 assays, DAP10 blocking antibody in transformed keratinocytes","pmids":["25002577"],"confidence":"Medium","gaps":["Physiological relevance of RAGE–DAP10 in vivo not tested","Whether the YINM motif mediates PI3K recruitment in the RAGE context not shown","Single lab observation"]},{"year":2015,"claim":"Ligand-induced ubiquitylation of DAP10 was shown to drive NKG2D–DAP10 endocytosis, and this endosomal trafficking was required for ERK activation and effector functions (granule release, IFN-γ), revealing that DAP10 signals from endosomes, not only from the plasma membrane.","evidence":"Ubiquitylation biochemistry, dominant-negative ubiquitin, confocal endocytosis imaging, ERK and effector function assays in human NK cells","pmids":["26508790"],"confidence":"High","gaps":["E3 ligase responsible for DAP10 ubiquitylation not identified","Specific ubiquitin chain type (K48 vs. K63) not determined","Whether endosomal signaling applies to non-NKG2D complexes unknown"]},{"year":2019,"claim":"EVL was identified as a DAP10-recruited actin regulator at the NK synapse, binding through the same Grb2/Vav1 site, and required for F-actin generation and target cell killing, adding a direct cytoskeletal effector to the DAP10 signaling module.","evidence":"Co-IP of EVL–DAP10–Grb2–Vav1, siRNA knockdown with synapse imaging and cytotoxicity assays","pmids":["31235500"],"confidence":"High","gaps":["How EVL, Grb2, and Vav1 are coordinated at a single DAP10 motif structurally unresolved","Whether EVL is required for non-NKG2D DAP10 complexes untested"]},{"year":null,"claim":"Key unresolved questions include: the identity of the E3 ubiquitin ligase that ubiquitylates DAP10, the structural basis for simultaneous occupancy of the YINM motif by PI3K-p85 and Grb2–Vav1–EVL, the kinase(s) that phosphorylate the YINM tyrosine in different receptor contexts, and whether DAP10's role in osteoclastogenesis and RAGE signaling involves the same downstream effectors as in NK cells.","evidence":"","pmids":[],"confidence":"High","gaps":["E3 ligase for DAP10 ubiquitylation unidentified","No structural model of DAP10 signalosome","YINM kinase identity context-dependent and undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,4,8,17]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,2,15]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,10,19]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[14,23]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,4,7,8,15,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4,8,17,23]}],"complexes":["NKG2D–DAP10","MDL-1–DAP12–DAP10","TREM2–DAP12–DAP10"],"partners":["KLRK1","PIK3R1","GRB2","VAV1","EVL","TYROBP","TREM2","AGER"],"other_free_text":[]},"mechanistic_narrative":"HCST (DAP10) is a transmembrane adaptor protein that couples activating immunoreceptors—primarily NKG2D, but also Ly49H, MDL-1, TREM2, RAGE, and CD200AR—to intracellular signaling cascades in NK cells, T cells, osteoclasts, and keratinocytes [PMID:10426994, PMID:19251634, PMID:25002577, PMID:33829411]. Its cytoplasmic YINM motif simultaneously recruits the p85 subunit of PI3K and a Grb2–Vav1 complex; both interactions are required for full downstream activation of Akt, ERK, calcium flux, cytoskeletal polarization at the immunological synapse, and cytotoxic granule release [PMID:16582911, PMID:16887996, PMID:26508790]. DAP10 surface expression is regulated transcriptionally by TGF-β1 (which excludes RNA Pol II from the DAP10 promoter) and IL-21, and post-transcriptionally by γc cytokines that promote DAP10 protein synthesis and glycosylation required for NKG2D association and stabilization [PMID:21816829, PMID:16424177]. Ligand-induced ubiquitylation of DAP10 drives receptor endocytosis that is itself required for ERK signaling and effector function, while DAP10-deficient mice develop osteopetrosis and display altered NKT/Treg activation thresholds, revealing roles beyond lymphocyte cytotoxicity [PMID:26508790, PMID:17785813, PMID:19251634]."},"prefetch_data":{"uniprot":{"accession":"Q9UBK5","full_name":"Hematopoietic cell signal transducer","aliases":["DNAX-activation protein 10","Membrane protein DAP10","Transmembrane adapter protein KAP10"],"length_aa":93,"mass_kda":9.5,"function":"Transmembrane adapter protein which associates with KLRK1 to form an activation receptor KLRK1-HCST in lymphoid and myeloid cells; this receptor plays a major role in triggering cytotoxicity against target cells expressing cell surface ligands such as MHC class I chain-related MICA and MICB, and UL16-binding proteins (ULBPs); these ligands are up-regulated by stress conditions and pathological state such as viral infection and tumor transformation. Functions as a docking site for PI3-kinase PIK3R1 and GRB2. Interaction of ULBPs with KLRK1-HCST triggers calcium mobilization and activation of the PIK3R1, MAP2K/ERK, and JAK2/STAT5 signaling pathways. Both PIK3R1 and GRB2 are required for full KLRK1-HCST-mediated activation and ultimate killing of target cells. In NK cells, KLRK1-HCST signaling directly induces cytotoxicity and enhances cytokine production initiated via DAP12/TYROBP-associated receptors. In T-cells, it provides primarily costimulation for TCR-induced signals. KLRK1-HCST receptor plays a role in immune surveillance against tumors and is required for cytolysis of tumors cells; indeed, melanoma cells that do not express KLRK1 ligands escape from immune surveillance mediated by NK cells","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q9UBK5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HCST","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HCST","total_profiled":1310},"omim":[{"mim_id":"616802","title":"T CELL-INTERACTING ACTIVATING RECEPTOR ON MYELOID CELLS 1; TARM1","url":"https://www.omim.org/entry/616802"},{"mim_id":"616560","title":"CD300H ANTIGEN; CD300H","url":"https://www.omim.org/entry/616560"},{"mim_id":"616301","title":"CD300 ANTIGEN-LIKE FAMILY, MEMBER D; CD300LD","url":"https://www.omim.org/entry/616301"},{"mim_id":"611817","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1; KLRK1","url":"https://www.omim.org/entry/611817"},{"mim_id":"604089","title":"HEMATOPOIETIC CELL SIGNAL TRANSDUCER; HCST","url":"https://www.omim.org/entry/604089"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Golgi apparatus","reliability":"Uncertain"},{"location":"Vesicles","reliability":"Uncertain"},{"location":"Plasma membrane","reliability":"Uncertain"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":239.0},{"tissue":"lymphoid tissue","ntpm":112.5}],"url":"https://www.proteinatlas.org/search/HCST"},"hgnc":{"alias_symbol":["DAP10","DKFZP586C1522","KAP10"],"prev_symbol":["PIK3AP"]},"alphafold":{"accession":"Q9UBK5","domains":[{"cath_id":"-","chopping":"3-71","consensus_level":"medium","plddt":68.7725,"start":3,"end":71}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBK5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBK5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBK5-F1-predicted_aligned_error_v6.png","plddt_mean":67.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HCST","jax_strain_url":"https://www.jax.org/strain/search?query=HCST"},"sequence":{"accession":"Q9UBK5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBK5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBK5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBK5"}},"corpus_meta":[{"pmid":"10426994","id":"PMC_10426994","title":"An activating immunoreceptor complex formed by NKG2D and DAP10.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10426994","citation_count":791,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20484116","id":"PMC_20484116","title":"TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.","date":"2010","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20484116","citation_count":340,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12740575","id":"PMC_12740575","title":"NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.","date":"2003","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12740575","citation_count":278,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16582911","id":"PMC_16582911","title":"NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.","date":"2006","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16582911","citation_count":217,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11015446","id":"PMC_11015446","title":"DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.","date":"2000","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11015446","citation_count":190,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22438812","id":"PMC_22438812","title":"TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.","date":"2012","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/22438812","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16339517","id":"PMC_16339517","title":"Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16339517","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21816829","id":"PMC_21816829","title":"Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21816829","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16424177","id":"PMC_16424177","title":"IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16424177","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15365099","id":"PMC_15365099","title":"Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15365099","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10528161","id":"PMC_10528161","title":"Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10528161","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16887996","id":"PMC_16887996","title":"Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16887996","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19332875","id":"PMC_19332875","title":"Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection.","date":"2009","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19332875","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19251634","id":"PMC_19251634","title":"Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19251634","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26508790","id":"PMC_26508790","title":"Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells.","date":"2015","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/26508790","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19329438","id":"PMC_19329438","title":"The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19329438","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19075187","id":"PMC_19075187","title":"A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19075187","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25002577","id":"PMC_25002577","title":"DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25002577","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21706044","id":"PMC_21706044","title":"HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway.","date":"2011","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21706044","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32273277","id":"PMC_32273277","title":"A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma Models.","date":"2020","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/32273277","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10945225","id":"PMC_10945225","title":"DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family.","date":"2000","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/10945225","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32144940","id":"PMC_32144940","title":"T-cells expressing a chimeric-PD1-Dap10-CD3zeta receptor reduce tumour burden in multiple murine syngeneic models of solid cancer.","date":"2020","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32144940","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11398969","id":"PMC_11398969","title":"Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D.","date":"2001","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11398969","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28670716","id":"PMC_28670716","title":"Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.","date":"2017","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28670716","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28438315","id":"PMC_28438315","title":"TGF-β1 improving abnormal pregnancy outcomes induced by Toxoplasma gondii infection: Regulating NKG2D/DAP10 and killer subset of decidual NK cells.","date":"2017","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28438315","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31952789","id":"PMC_31952789","title":"A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31952789","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31235500","id":"PMC_31235500","title":"NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.","date":"2019","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/31235500","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17100879","id":"PMC_17100879","title":"Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity.","date":"2006","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17100879","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31143782","id":"PMC_31143782","title":"CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway.","date":"2019","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/31143782","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32106933","id":"PMC_32106933","title":"Inclusion of Dap10 or 4-1BB costimulation domains in the chPD1 receptor enhances anti-tumor efficacy of T cells in murine models of lymphoma and melanoma.","date":"2020","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32106933","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38468942","id":"PMC_38468942","title":"Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38468942","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35784403","id":"PMC_35784403","title":"DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D.","date":"2022","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/35784403","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33153411","id":"PMC_33153411","title":"CSF1R and HCST: Novel Candidate Biomarkers Predicting the Response to Immunotherapy in Non-Small Cell Lung Cancer.","date":"2020","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/33153411","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21789015","id":"PMC_21789015","title":"A possible mechanism of impaired NK cytotoxicity in cancer patients: down-regulation of DAP10 by TGF-beta1.","date":"2011","source":"Tumori","url":"https://pubmed.ncbi.nlm.nih.gov/21789015","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22084441","id":"PMC_22084441","title":"Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22084441","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19247984","id":"PMC_19247984","title":"DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo.","date":"2009","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19247984","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26442832","id":"PMC_26442832","title":"Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma.","date":"2015","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26442832","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17785813","id":"PMC_17785813","title":"DAP10 deficiency breaks the immune tolerance against transplantable syngeneic melanoma.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17785813","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35988132","id":"PMC_35988132","title":"TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects.","date":"2022","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/35988132","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35965586","id":"PMC_35965586","title":"Combination of 4-1BB and DAP10 promotes proliferation and persistence of NKG2D(bbz) CAR-T cells.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35965586","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33829411","id":"PMC_33829411","title":"CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.","date":"2021","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/33829411","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17530242","id":"PMC_17530242","title":"Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17530242","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14635062","id":"PMC_14635062","title":"Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14635062","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21122940","id":"PMC_21122940","title":"DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.","date":"2010","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21122940","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37475556","id":"PMC_37475556","title":"HCST Expression Distinguishes Immune-hot and Immune-cold Subtypes in Pancreatic Ductal Adenocarcinoma.","date":"2025","source":"Current gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37475556","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34868314","id":"PMC_34868314","title":"DAP10 Predicted the Outcome of Pediatric B-Cell Acute Lymphoblastic Leukemia and Was Associated with the T-Cell Exhaustion.","date":"2021","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34868314","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30345220","id":"PMC_30345220","title":"Age-Based Reproductive Healthcare Stereotype Threat (HCST) as a Stressor Affecting Prenatal Mental Health in Pregnant Women of Advanced Maternal Age: Measurement, Process, Outcomes, and Interactions with Ethnicity/Race, SES, and Other Social Identities.","date":"2017","source":"Current epidemiology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30345220","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35217362","id":"PMC_35217362","title":"A chimeric switch-receptor PD1-DAP10-41BB augments NK92-cell activation and killing for human lung Cancer H1299 Cell.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/35217362","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41495583","id":"PMC_41495583","title":"cGAMP Enhances Microglial/Macrophage Phagocytosis in Ischemic Stroke Via Activation of the TREM2-DAP10-PI3K Pathway.","date":"2026","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/41495583","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33307474","id":"PMC_33307474","title":"The impact of chimerism on DNA-based human identification from skin surface cells of post-allogenic hematopoietic stem cell transplantation (HCST) patients.","date":"2020","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/33307474","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40393250","id":"PMC_40393250","title":"Dap10 co-stimulation enhances the anti-HCC efficacy of NKp30 chimeric antigen receptor T cells.","date":"2025","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/40393250","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39412658","id":"PMC_39412658","title":"A girl with a novel nonsense mutation in Chediak-Higashi syndrome was relieved successfully by treatment with HCST and UCBT: a case report.","date":"2024","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/39412658","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.05.639198","title":"ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation","date":"2025-03-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.05.639198","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8617505","id":"PMC_8617505","title":"The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8617505","citation_count":1095,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23251661","id":"PMC_23251661","title":"Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23251661","citation_count":312,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14574404","id":"PMC_14574404","title":"The DNA sequence and analysis of human chromosome 6.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/14574404","citation_count":242,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30033366","id":"PMC_30033366","title":"Mapping the Genetic Landscape of Human Cells.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30033366","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18461144","id":"PMC_18461144","title":"Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18461144","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8755516","id":"PMC_8755516","title":"Expression cloning of the Golgi CMP-sialic acid transporter.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8755516","citation_count":141,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15576474","id":"PMC_15576474","title":"Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15576474","citation_count":117,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32694731","id":"PMC_32694731","title":"Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.","date":"2020","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32694731","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9010752","id":"PMC_9010752","title":"Molecular cloning and characterization of a novel isoform of the human UDP-galactose transporter, and of related complementary DNAs belonging to the nucleotide-sugar transporter gene family.","date":"1996","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9010752","citation_count":82,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28298427","id":"PMC_28298427","title":"Systematic protein-protein interaction mapping for clinically relevant human GPCRs.","date":"2017","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/28298427","citation_count":58,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24623722","id":"PMC_24623722","title":"Systematic identification of pathological lamin A interactors.","date":"2014","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/24623722","citation_count":56,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23873973","id":"PMC_23873973","title":"Intellectual disability and bleeding diathesis due to deficient CMP--sialic acid transport.","date":"2013","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23873973","citation_count":47,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12682060","id":"PMC_12682060","title":"Substrate recognition by nucleotide sugar transporters: further characterization of substrate recognition regions by analyses of UDP-galactose/CMP-sialic acid transporter chimeras and biochemical analysis of the substrate specificity of parental and chimeric transporters.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12682060","citation_count":45,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30115659","id":"PMC_30115659","title":"A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formation.","date":"2018","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/30115659","citation_count":42,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31741433","id":"PMC_31741433","title":"Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31741433","citation_count":42,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16923816","id":"PMC_16923816","title":"The CMP-sialic acid transporter is localized in the medial-trans Golgi and possesses two specific endoplasmic reticulum export motifs in its carboxyl-terminal cytoplasmic tail.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16923816","citation_count":40,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9644260","id":"PMC_9644260","title":"Functional expression of human golgi CMP-sialic acid transporter in the Golgi complex of a transporter-deficient Chinese hamster ovary cell mutant.","date":"1998","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9644260","citation_count":35,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32303557","id":"PMC_32303557","title":"Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver.","date":"2021","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/32303557","citation_count":32,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26066,"output_tokens":3983,"usd":0.068972},"stage2":{"model":"claude-opus-4-6","input_tokens":7430,"output_tokens":3424,"usd":0.184125},"total_usd":0.571292,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":39085,"output_tokens":7947,"usd":0.11823},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":11612,"output_tokens":3010,"usd":0.199965}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"DAP10 (KAP10/HCST) forms an activating immunoreceptor complex with NKG2D on NK and T cells; the DAP10 cytoplasmic domain contains a YINM (YxxM) motif that recruits the p85 subunit of PI3-kinase, enabling NKG2D-dependent signal transduction.\",\n      \"method\": \"Cell surface expression assays, co-immunoprecipitation, SH2 domain binding assays, transfection experiments\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original discovery with co-IP, functional binding assays, replicated across multiple subsequent labs\",\n      \"pmids\": [\"10426994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DAP10 (KAP10) is genetically linked to DAP12, encoded within 100 bp of the DAP12 locus on human chromosome 19, and its cytoplasmic YINM motif binds PI3-kinase and the adaptor protein Grb2, leading to Akt activation.\",\n      \"method\": \"Molecular cloning, co-immunoprecipitation, transfection, kinase activation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — independent lab, in vitro binding and functional assays with mutagenesis context\",\n      \"pmids\": [\"10528161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The transmembrane regions of DAP10 and DAP12 are sufficient to confer specific association with their respective ligand-binding receptor partners; DAP10- and DAP12-associated receptors cooperate synergistically for cytokine production, with DAP10 activating the PI3K pathway (via YxNM motif) and DAP12 activating Syk/ZAP70 (via ITAM).\",\n      \"method\": \"Transfection, co-immunoprecipitation, NK cell functional assays (cytotoxicity, cytokine production), transmembrane domain swap mutants\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal Co-IP, domain mutagenesis, functional readouts, replicated findings\",\n      \"pmids\": [\"11015446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The YINM motif in the DAP10 cytoplasmic tail couples NKG2D receptor stimulation to downstream activation of PI3K, Vav1, Rho family GTPases, and phospholipase C, independently of Syk family kinases, and is sufficient to trigger NK cell killing.\",\n      \"method\": \"Mutational analysis of DAP10 YINM motif, kinase activity assays, redirected lysis assays, signaling pathway inhibitors\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site/motif mutagenesis combined with functional assays, strong mechanistic follow-up\",\n      \"pmids\": [\"12740575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Vav1, but not Vav2 or Vav3, is specifically required for DAP10-mediated NK cell cytotoxicity, while Vav2 and Vav3 are required for FcRgamma- and DAP12-mediated cytotoxicity, demonstrating pathway-specific roles for Vav family members downstream of DAP10.\",\n      \"method\": \"Genetic knockout mice lacking one, two, or all three Vav proteins; NK cell cytotoxicity assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis using multiple knockout combinations with clean cytotoxicity readout\",\n      \"pmids\": [\"15365099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DAP10 recruits a Grb2-Vav1 intermediate complex; binding of both the Grb2-Vav1 complex and p85 (PI3K) to DAP10 is required for full calcium release and cytotoxicity. Grb2-Vav1 binding alone initiates tyrosine phosphorylation, but full activation requires both interactions.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative constructs, calcium flux assays, cytotoxicity assays, mutational analysis of DAP10 binding sites\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods, mutagenesis, functional readouts in same study\",\n      \"pmids\": [\"16582911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Vav1 interacts with DAP10 YxNM motifs through the adaptor Grb2 and is required for DAP10-induced NK cell cytoskeletal polarization (actin and microtubule networks), maturation of the cytolytic synapse, and PI3K-dependent Akt signaling.\",\n      \"method\": \"Vav1/DAP12 double-knockout mice, co-immunoprecipitation, confocal microscopy of cytoskeletal dynamics, cytotoxicity assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined cellular phenotype, Co-IP, imaging, multiple orthogonal methods\",\n      \"pmids\": [\"16887996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IL-21 reduces DAP10 transcription by decreasing DAP10 promoter activity, leading to downregulation of NKG2D-DAP10 surface expression and impaired NK cell cytotoxicity and degranulation.\",\n      \"method\": \"DAP10 luciferase reporter assays, flow cytometry, redirected lysis assays, degranulation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay and functional assays, single lab\",\n      \"pmids\": [\"16424177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DAP10 associates with the MDL-1 receptor in osteoclasts, forming MDL-1-DAP12/DAP10 trimolecular complexes; DAP10 deficiency causes osteopetrosis with reduced osteoclasts in vivo, demonstrating DAP10's role in osteoclastogenesis and bone remodeling through YINM costimulatory motif signaling.\",\n      \"method\": \"DAP10 knockout mice (osteopetrosis phenotype), co-immunoprecipitation identifying MDL-1-DAP12-DAP10 complex, in vitro osteoclastogenesis assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined skeletal phenotype, receptor identification by Co-IP, in vitro functional confirmation\",\n      \"pmids\": [\"19251634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ly49H associates with and signals through DAP10 in addition to DAP12 for optimal NK cell function during MCMV infection; in the absence of DAP12, DAP10 enables Ly49H-mediated killing, proliferation, and partial protection against MCMV.\",\n      \"method\": \"DAP10-deficient mice, DAP12-deficient mice, double-KO mice; NK cell cytotoxicity assays, proliferation assays, MCMV infection model, ERK1/2 activation assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple KO combinations, in vivo infection model, defined functional readouts\",\n      \"pmids\": [\"19332875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Upon NKG2D-MICB engagement, DAP10 traffics to secretory lysosomes and is degraded via lysosomal pathway; an intracellular recycling pool of NKG2D-DAP10 exists in activated NK cells that replenishes surface receptor.\",\n      \"method\": \"Confocal microscopy, subcellular fractionation, flow cytometry, live imaging of NK cell-target cell interactions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization experiment with functional consequence, single lab\",\n      \"pmids\": [\"19329438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TREM2-DAP12-dependent PI3K activation requires DAP10 as a co-signaling adaptor; SHIP1 inhibits this pathway by binding DAP12 via its SH2 domain and preventing PI3K recruitment to the complex.\",\n      \"method\": \"Co-immunoprecipitation, kinase activation assays, DAP10/DAP12-deficient macrophages, SHIP1 SH2 domain mutants\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods, mutagenesis, genetic deficiency models, replicated in multiple cell types\",\n      \"pmids\": [\"20484116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"IL-2 up-regulates DAP10 protein synthesis posttranscriptionally; newly synthesized DAP10 undergoes glycosylation required for DAP10 association with NKG2D and stabilization of NKG2D surface expression. TGF-β1 inhibits DAP10 transcription by blocking RNA polymerase II association with the DAP10 promoter.\",\n      \"method\": \"Western blotting, metabolic labeling, glycosylation inhibitors, ChIP assay (RNA Pol II), flow cytometry, reporter assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including ChIP and biochemical modification analysis, mechanistic detail\",\n      \"pmids\": [\"21816829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DAP10 physically associates with RAGE (receptor for advanced glycation end products) in keratinocytes; RAGE-DAP10 heterodimer formation markedly enhances Akt activation (pro-survival), while RAGE homomultimers activate caspase 8 (pro-apoptotic). Functional blocking of DAP10 abrogates Akt phosphorylation from S100A8/A9-activated RAGE.\",\n      \"method\": \"Co-immunoprecipitation, artificial oligomerization system, Akt/caspase 8 activity assays, DAP10 blocking antibody, overexpression in cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP, functional blocking, signaling readouts, single lab\",\n      \"pmids\": [\"25002577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Ligand-induced endocytosis of NKG2D-DAP10 complexes depends on ubiquitylation of DAP10; ubiquitin-dependent receptor endocytosis is required for activation of ERK and NK cell effector functions (cytotoxic granule secretion and IFN-γ production), not merely for receptor downregulation.\",\n      \"method\": \"Ubiquitylation assays, endocytosis assays, ERK activation assays, degranulation and cytokine secretion assays, biochemical and microscopic analyses\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — combined biochemical and microscopic analyses with defined functional consequences, mechanistic link between PTM and signaling outcome\",\n      \"pmids\": [\"26508790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DAP10 recruits EVL (Ena/VASP-like) to the NK cell cytotoxic synapse via the same binding site used for Grb2/VAV1 recruitment; EVL is required for F-actin generation at the synapse, NK cell-target cell adhesion, and cytotoxicity.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy of synapse formation, siRNA knockdown, spreading assays, cytotoxicity assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP, imaging, KD with functional readout, single lab\",\n      \"pmids\": [\"31235500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ACLY-deficiency in NK cells results in decreased DAP12 and increased DAP10 transcript and protein levels, with altered histone acetylation at the DAP10 and DAP12 gene loci, demonstrating that epigenetic regulation via acetyl-CoA controls DAP10 expression and downstream activating receptor function.\",\n      \"method\": \"Inducible genetic KO mouse model, transcriptomics, epigenetic profiling (histone acetylation), acetate supplementation rescue experiments, NK cell functional assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with epigenetic profiling and rescue experiment, preprint\",\n      \"pmids\": [\"bio_10.1101_2025.03.05.639198\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"DAP10 (HCST) is a transmembrane signaling adaptor that forms obligate complexes with NKG2D (and other receptors including MDL-1, RAGE, and select Ly49 receptors) via charged transmembrane residues, and signals through its cytoplasmic YINM motif by simultaneously recruiting the p85 subunit of PI3K and a Grb2-Vav1 intermediate complex; both interactions are required for full downstream activation including PI3K-Akt, Vav1-mediated Rho GTPase activation, cytoskeletal polarization, and ERK activation, which collectively drive NK and T cell cytotoxicity, degranulation, and cytokine production, while the complex is regulated post-translationally by DAP10 glycosylation (required for NKG2D stabilization), ubiquitylation (required for productive endosomal signaling), and transcriptionally by TGF-β1 (suppression via RNA Pol II exclusion) and γc cytokines (enhancement), and epigenetically via ACLY-generated acetyl-CoA.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification:**\n\nHCST = DAP10 (DNAX-activating protein 10, also called KAP10) — the transmembrane adaptor protein that partners with NKG2D.\n\n**KEEP papers** (about DAP10/HCST canonical protein):\n- Papers [1]-[19], [21], [23], [27]-[29], [35]-[36], [38], [41]-[44], [53] from the retrieved corpus\n- Papers [20], [22], [24], [25], [26], [30], [31], [32], [39], [40], [48], [51] — CAR-T engineering studies using DAP10 domain; include only if they reveal mechanistic findings about DAP10 function itself\n\n**EXCLUDE:**\n- Paper [47]: HCST = \"Healthcare Stereotype Threat\" — alias collision (A)\n- Paper [50]: HCST = \"hematopoietic stem cell transplantation\" abbreviation — alias collision (A)\n- Paper [52]: HCST = \"hematopoietic stem cell transplantation\" — alias collision (A)\n- Papers [33], [45], [46]: expression/biomarker studies, no mechanism\n- Gene2pubmed papers [1]-[30]: mostly cDNA repositories, interactome databases, SLC35A1/CMP-sialic acid transporter papers (alias collision), GWAS — exclude all (no mechanistic findings about DAP10/HCST specifically)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"DAP10 (HCST/KAP10) was identified as a transmembrane adaptor protein that forms an activating immunoreceptor complex with NKG2D on NK and T cells, recognizing the stress-inducible MHC molecule MICA. The cytoplasmic YINM (YxxM) motif of DAP10 recruits the p85 subunit of PI3-kinase, providing NKG2D-dependent signal transduction.\",\n      \"method\": \"Co-immunoprecipitation, transfection/expression studies, PI3K recruitment assay, cell surface expression analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — original discovery with biochemical reconstitution of complex, PI3K binding demonstrated, replicated across multiple subsequent studies\",\n      \"pmids\": [\"10426994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DAP10 (KAP10) is genetically linked to DAP12 on human chromosome 19 and, unlike ITAM-containing adaptors, signals via phosphorylation of its cytoplasmic YINM motif to activate PI3K and downstream Akt, rather than recruiting Syk-family kinases. DAP10 can also bind the adaptor protein Grb2.\",\n      \"method\": \"Molecular cloning, sequence analysis, transfection, PI3K/Akt activation assays, Grb2 binding assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — original cloning with functional characterization of signaling motif, replicated in subsequent studies\",\n      \"pmids\": [\"10528161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Despite high similarity between DAP10 and DAP12, their transmembrane regions are sufficient to confer specific association with distinct ligand-binding receptor partners. DAP10 signals via the PI3K pathway (YxNM motif), while DAP12 signals via Syk/ZAP70 through its ITAM motif. Cross-linking of either DAP10- or DAP12-associated receptors alone can trigger NK cytotoxicity, but synergy occurs in cytokine production when both are co-engaged.\",\n      \"method\": \"Transfection with transmembrane domain swap mutants, NK cell cytotoxicity assays, cytokine production assays, co-immunoprecipitation\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal domain-swap experiments with functional readouts, replicated across labs\",\n      \"pmids\": [\"11015446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Pig DAP10 contains conserved structural features including an aspartic acid in the transmembrane domain, two cysteines in the extracellular domain, and a PI3K-binding YxxM motif in the cytoplasmic region. Pig NKG2D requires DAP10 for cell surface expression when transiently transfected into COS-7 cells, demonstrating the conserved requirement for DAP10 in NKG2D surface trafficking.\",\n      \"method\": \"cDNA cloning, sequence analysis, transient transfection in COS-7 cells, cell surface expression by flow cytometry\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab, functional demonstration of DAP10-dependent NKG2D surface expression in heterologous cells\",\n      \"pmids\": [\"11398969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A critical YINM amino acid motif in the DAP10 cytoplasmic tail couples NKG2D receptor stimulation to activation of PI3K, Vav1, Rho family GTPases, and phospholipase C, triggering NK cell killing independently of Syk family tyrosine kinases. This defines a Syk-independent activation pathway for ITAM-lacking receptor complexes.\",\n      \"method\": \"Mutational analysis of DAP10 cytoplasmic YINM motif, NK cell killing assays, signaling pathway analysis (PI3K, Vav1, Rho GTPase, PLC activation), Syk kinase inhibition\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis of key motif combined with multiple orthogonal signaling assays and functional cytotoxicity readout\",\n      \"pmids\": [\"12740575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SIRPβ1 can associate with DAP10 in transfected RBL-2H3 cells, but engagement of SIRPβ1–DAP10 complexes alone does not trigger serotonin release or TNF secretion; instead, DAP10 provides co-stimulatory activity that enhances FcεRI-mediated effector functions under sub-optimal stimulation conditions, demonstrating that DAP10's signaling output is context-dependent.\",\n      \"method\": \"Transfection of RBL-2H3 cells, co-immunoprecipitation, serotonin release assay, TNF secretion assay, FcεRI co-stimulation assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in a defined cell model, single lab\",\n      \"pmids\": [\"14635062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Using mice lacking one, two, or all three Vav family proteins, Vav1 deficiency alone is sufficient to disrupt DAP10-mediated NK cell cytotoxicity, whereas Vav2 and Vav3 are preferentially required for FcRγ- and DAP12-mediated cytotoxicity. This places Vav1 specifically downstream of DAP10 in NK cell activation.\",\n      \"method\": \"Genetic epistasis using Vav1/2/3 single, double, and triple knockout mice; NK cell cytotoxicity assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — clean genetic epistasis with multiple knockout combinations and defined functional readout\",\n      \"pmids\": [\"15365099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Stable RNA interference-mediated silencing of DAP10 (and NKG2D or DAP12) in human CD8+ T cells and NK cells reduces cytolysis of tumor cells including autologous ovarian cancer cells, and abolishes in vivo antitumor activity, demonstrating that DAP10 is required for effector cell function.\",\n      \"method\": \"Lentiviral stable shRNA knockdown, in vitro tumor cytolysis assays, in vivo antitumor model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — stable KD with both in vitro and in vivo functional readouts, multiple target genes confirmed\",\n      \"pmids\": [\"16339517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"For NKG2D-DAP10-mediated cytotoxicity, both Grb2–Vav1 binding and p85 PI3K binding to the DAP10 YINM motif are required. Grb2–Vav1 binding to DAP10 is sufficient to initiate tyrosine phosphorylation events, but full calcium release and cytotoxicity require the simultaneous recruitment of both Grb2–Vav1 and p85 to the same DAP10 motif.\",\n      \"method\": \"Dominant-negative constructs, point mutations of DAP10 YINM motif, co-immunoprecipitation, calcium flux assays, NK cell cytotoxicity assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with multiple orthogonal assays (Co-IP, calcium, cytotoxicity), strong mechanistic resolution\",\n      \"pmids\": [\"16582911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Vav1 is a critical signaling mediator downstream of DAP10 in NK cells, required for DAP10-induced cytoskeletal polarization involving both actin and microtubule networks, maturation of the cytolytic synapse, and target cell lysis. Vav1 interacts with DAP10 YINM motifs through the adaptor Grb2 and is required for activation of PI3K-dependent Akt signaling downstream of DAP10.\",\n      \"method\": \"Vav1/DAP12 double-knockout mice, NK cell cytoskeletal polarization assays (imaging), synapse maturation analysis, cytotoxicity assays, Co-IP of Vav1–Grb2–DAP10\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic model combined with imaging and biochemical assays, multiple orthogonal methods\",\n      \"pmids\": [\"16887996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IL-21 down-regulates NKG2D–DAP10 surface expression on human NK and CD8+ T cells by markedly reducing DAP10 transcription, as demonstrated by reduced DAP10 promoter activity in a luciferase reporter assay. This functional loss of DAP10 correlates with impaired NKG2D-mediated NK cell cytotoxicity and degranulation.\",\n      \"method\": \"Primary NK/CD8+ T cell culture with cytokines, flow cytometry, DAP10 luciferase reporter assay, redirected lysis assay, degranulation assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — promoter reporter assay directly demonstrates transcriptional mechanism, corroborated with functional readouts\",\n      \"pmids\": [\"16424177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DAP10-deficient mice develop osteopetrosis with age due to reduced osteoclast numbers, revealing a physiological role for DAP10 in bone remodeling. DAP10 deficiency also results in hyperactive NKT cell functions and impaired regulatory T cell (Treg) activation, showing that constitutive DAP10 signaling regulates immune tolerance by adjusting the activation threshold of NKT cells and Tregs.\",\n      \"method\": \"DAP10 knockout mouse analysis, bone histology, NK/NKT cell functional assays (cytotoxicity, cytokine), Treg activation assays (IL-2, IL-10, IFN-γ production)\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple cellular phenotype readouts, single lab\",\n      \"pmids\": [\"17785813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LGLL cells express elevated DAP10 and DAP12 with constitutively activated downstream targets. Expression of dominant-negative DAP10 dramatically reduces the lytic capacity of LGLL CD8+CD28null T cells against pulmonary artery endothelial and synovial cells, demonstrating that DAP10 signaling is required for enhanced cytotoxicity in this leukemia.\",\n      \"method\": \"Dominant-negative DAP10 expression, cytotoxicity assays against endothelial and synovial target cells, western blot for constitutive downstream signaling\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative functional experiment with specific cellular phenotype, single lab\",\n      \"pmids\": [\"19075187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DAP10 associates with the myeloid receptor MDL-1, which also associates with DAP12. In osteoclasts and bone marrow-derived macrophages, MDL-1 forms trimolecular complexes with both DAP12 and DAP10 (ITAM/YINM motifs), and DAP10 association with MDL-1 depends almost entirely on DAP12, suggesting DAP12-dependent recruitment of DAP10 into the complex. DAP10-deficient mice become osteopetrotic, confirming DAP10's role in osteoclastogenesis.\",\n      \"method\": \"Co-immunoprecipitation of MDL-1–DAP12–DAP10 complexes, DAP10 knockout mouse bone phenotype analysis, in vitro osteoclastogenesis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP identifying trimolecular complex, corroborated with KO mouse phenotype and in vitro functional assay\",\n      \"pmids\": [\"19251634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"During NK cell activation, exposure to MICB-expressing target cells causes lysosomal degradation of DAP10, with approximately 50% of total NKG2D protein degraded. DAP10 traffics to secretory lysosomes in activated NK cells upon interaction with MICB-expressing targets, and polarization of DAP10-containing secretory lysosomes to the cytotoxic immune synapse is observed, suggesting that rapid DAP10/NKG2D degradation upon synapse formation explains receptor down-regulation after chronic ligand exposure.\",\n      \"method\": \"Confocal microscopy, lysosomal inhibitor treatment, subcellular fractionation, flow cytometry for NKG2D surface expression kinetics in NKL cells and primary NK cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell imaging and fractionation experiments linking DAP10 trafficking to functional consequence\",\n      \"pmids\": [\"19329438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ly49H must associate with and signal via both DAP10 and DAP12 for optimal NK cell function during MCMV infection. In the absence of DAP12, DAP10 enables Ly49H-mediated target cell killing and proliferation. DAP10-deficient Ly49H+ NK cells show diminished ERK1/2 activation, reduced IFN-γ production, and impaired control of MCMV infection, demonstrating that DAP10 contributes distinct signaling outputs (ERK activation, cytokine production) to the Ly49H receptor complex.\",\n      \"method\": \"DAP10 and DAP12 single/double knockout mice, MCMV infection model, NK cell cytotoxicity assays, proliferation assays, ERK1/2 phosphorylation, IFN-γ production, viral titer measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic models with multiple orthogonal functional and signaling readouts in vivo\",\n      \"pmids\": [\"19332875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DAP10 associates with Ly49H and Ly49D in primary mouse NK cells, slightly contributing to their cell surface expression, but this association has no significant impact on Ly49H-mediated control of MCMV infection in physiological conditions, indicating that functional consequences of DAP10 association vary widely among activating NK receptors.\",\n      \"method\": \"Co-immunoprecipitation from primary NK cells, flow cytometry for receptor surface expression, MCMV infection model in DAP10-deficient mice\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP from primary cells with in vivo functional test, single lab\",\n      \"pmids\": [\"19247984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TREM2/DAP12-dependent activation of PI3K requires DAP10 as a co-signaling adaptor. Ligation of TREM2 activates PI3K, ERK1/2, and Vav3; induces Ca2+ mobilization and actin reorganization; and prevents apoptosis. DAP10 is essential for recruitment of PI3K to the TREM2–DAP12 signaling complex. SHIP1 inhibits this pathway by binding DAP12 via its SH2 domain, preventing PI3K recruitment to DAP12.\",\n      \"method\": \"TREM2 ligation assays, PI3K recruitment assays, ERK/Vav3/Ca2+ activation assays, actin reorganization microscopy, DAP10-deficient cells, SHIP1 SH2 domain mutant experiments, co-immunoprecipitation\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal signaling assays, domain mutants, genetic DAP10-deficiency model, replicated across several readouts\",\n      \"pmids\": [\"20484116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DAP10 contributes to CD8+ T cell-mediated cytotoxicity during Mycobacterium tuberculosis infection. DAP10-deficient mice show significantly reduced CD8 T cell-mediated cytotoxicity during Mtb infection, associated with impaired cytotoxic granule release, without affecting CD8 T cell recruitment, activation, or IFN-γ production frequency.\",\n      \"method\": \"DAP10 knockout mouse aerosol Mtb infection model, CD8 T cell cytotoxicity assays, granule release assay, flow cytometry for T cell activation markers and IFN-γ\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with specific cytolytic phenotype in infection model, single lab\",\n      \"pmids\": [\"21122940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"IL-2 and γc cytokines up-regulate DAP10 expression primarily at the posttranscriptional level, increasing DAP10 protein synthesis. Newly synthesized DAP10 undergoes glycosylation that is required for its association with NKG2D and stabilization of NKG2D surface expression. TGF-β1 exerts an opposing dominant effect by inhibiting RNA polymerase II association with the DAP10 promoter, decreasing DAP10 mRNA, which causes secondary loss of NKG2D protein.\",\n      \"method\": \"NK cell cytokine stimulation, qRT-PCR, immunoblotting, chromatin immunoprecipitation (RNA Pol II at DAP10 promoter), co-immunoprecipitation of DAP10–NKG2D, glycosylation inhibitor treatment\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP demonstrates transcriptional mechanism, glycosylation experiments link PTM to NKG2D association, multiple orthogonal approaches\",\n      \"pmids\": [\"21816829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In rodents (rat and mouse), DAP10 and DAP12 associate not with NKG2C/E but with CD94, via a transmembrane lysine residue unique to rodent CD94. This represents a phylogenetic transfer of adaptor-binding capacity from NKG2C/E to the CD94 chain, demonstrating that DAP10 association with NK receptor complexes is mediated by specific transmembrane charged residue interactions.\",\n      \"method\": \"Transfection with NKG2C mutant constructs, flow cytometry, biochemical co-immunoprecipitation from primary rat NK cells, redirected lysis assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical Co-IP and mutational analysis, single lab, functional validation\",\n      \"pmids\": [\"22084441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TGF-β1 down-regulates both DAP10 and NKG2D surface expression on NK cells from HBV-infected patients, impairing NK cell cytotoxicity and IFN-γ production. In vitro, TGF-β1 treatment recapitulates this down-regulation, and anti-TGF-β1 antibodies restore NKG2D and DAP10 expression, placing TGF-β1 as a key negative regulator of the NKG2D–DAP10 pathway during chronic viral infection.\",\n      \"method\": \"Flow cytometry of NK cells from HBV patients and healthy controls, in vitro TGF-β1 treatment, anti-TGF-β1 antibody restoration experiments, NK cell cytotoxicity and IFN-γ assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — antibody rescue experiment supports mechanism, but primarily patient sample data with limited mechanistic depth\",\n      \"pmids\": [\"22438812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DAP10 associates with the receptor for advanced glycation end products (RAGE) in human keratinocytes. RAGE–DAP10 heterodimer formation markedly enhances Akt activation (pro-survival signaling), whereas homomultimeric RAGE interaction leads to caspase-8 activation and apoptosis. Functional blocking of DAP10 in transformed keratinocyte lines abrogates Akt phosphorylation from S100A8/A9-activated RAGE, leading to increased apoptosis.\",\n      \"method\": \"Artificial oligomerization assay, co-immunoprecipitation of RAGE–DAP10, Akt phosphorylation assay, caspase-8 activation assay, DAP10 functional blocking antibody, DAP10-overexpressing cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel binding partner identified with functional consequences using multiple assays, single lab\",\n      \"pmids\": [\"25002577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Ligand-induced endocytosis of NKG2D–DAP10 complexes in human NK cells depends on ubiquitylation of DAP10. This ubiquitin-dependent endocytosis is required not only for degradation of internalized receptor complexes but also for activation of ERK and NK cell effector functions including cytotoxic granule secretion and IFN-γ production, demonstrating that endosomal DAP10 signaling is functionally critical.\",\n      \"method\": \"Biochemical ubiquitylation assays, dominant-negative ubiquitin constructs, confocal microscopy of receptor endocytosis, ERK activation assays, cytotoxic granule secretion assay, IFN-γ production assay in human NK cells\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ubiquitylation biochemistry combined with dominant-negative functional experiments and multiple effector function readouts\",\n      \"pmids\": [\"26508790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"EVL (Ena/VASP-like), an actin regulatory protein, is recruited to the NK cell cytotoxic synapse via NKG2D–DAP10 signaling, through the same binding site on DAP10 previously implicated in Vav1 and Grb2 recruitment. EVL interacts with WASP and VASP and is required for F-actin generation at the synapse, NK cell–target cell adhesion, and cytotoxicity.\",\n      \"method\": \"Co-immunoprecipitation of EVL with DAP10/Grb2/Vav1, confocal microscopy of synapse recruitment, siRNA knockdown of EVL, F-actin quantification at synapse, NK cell adhesion and cytotoxicity assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP identifies novel binding partner at known DAP10 site, KD with multiple orthogonal functional and imaging readouts\",\n      \"pmids\": [\"31235500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD33 (Siglec-3) preferentially inhibits NKG2D/DAP10-mediated NK cell cytotoxicity. CD33-mediated inhibition of NKG2D-triggered cytotoxicity involves dephosphorylation of Vav1, placing Vav1 as a convergence point between the DAP10 activating pathway and CD33 inhibitory signaling.\",\n      \"method\": \"NK cell and NKL cell cytotoxicity assays with CD33 co-engagement, phospho-Vav1 western blot, comparison with ILT-2/CD94-NKG2A inhibitory receptors\",\n      \"journal\": \"Journal of immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — phospho-signaling readout with functional cytotoxicity data, single lab\",\n      \"pmids\": [\"31143782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD200AR-L/CD200AR binding signals through DAP10 (not DAP12) to control anti-glioma tumor immunity in vivo. The CD200AR–DAP10 pathway shows initial activation followed by transient decrease and reactivation via a positive feedback loop. In vivo studies using DAP10/DAP12 knockout mice confirm that DAP10, but not DAP12, is required for tumor control by this immune checkpoint receptor pathway.\",\n      \"method\": \"Transcription, protein, and phosphorylation analysis in vitro; DAP10/DAP12 double-KO mouse glioma model; pharmacological inhibitor studies; intracranial GBM model survival assay\",\n      \"journal\": \"Neurotherapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO model confirms DAP10-specificity in vivo, with in vitro signaling characterization\",\n      \"pmids\": [\"33829411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ACLY-deficient NK cells show decreased DAP12 and increased DAP10 transcript and protein levels. Epigenetic profiling demonstrates altered histone acetylation at the DAP10 and DAP12 gene loci in ACLY KO cells. Acetate supplementation restores DAP10/DAP12 expression and activating receptor function, demonstrating that cytosolic acetyl-CoA generated by ACLY controls DAP10 and DAP12 expression through histone acetylation.\",\n      \"method\": \"Inducible ACLY knockout mouse model, RNA-seq, western blot, epigenetic/histone acetylation profiling (ChIP), acetate supplementation rescue, NK cell functional assays (cytotoxicity, cytokine)\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with epigenetic profiling and rescue experiment; preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.03.05.639198\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"HCST (DAP10) is a transmembrane adaptor protein that forms activating immunoreceptor complexes with NKG2D (and other receptors including MDL-1, RAGE, and Ly49H) on NK and T cells; its cytoplasmic YINM motif recruits both the p85 subunit of PI3K and a Grb2–Vav1 intermediate simultaneously—both interactions being required for full downstream signaling including PI3K/Akt activation, Vav1-mediated cytoskeletal polarization (actin and microtubule networks), ERK activation, calcium flux, and cytotoxic granule secretion; ligand-induced DAP10 ubiquitylation drives endocytosis required for ERK signaling and effector functions, while DAP10 surface expression is regulated transcriptionally (by TGF-β1 via RNA Pol II exclusion from the DAP10 promoter, and by IL-21 via promoter repression) and post-transcriptionally (by γc cytokines promoting DAP10 synthesis and glycosylation, the latter being required for NKG2D association and stabilization).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DAP10 (HCST) is a transmembrane signaling adaptor that couples activating immunoreceptors—principally NKG2D, but also MDL-1, Ly49H, RAGE, and TREM2-DAP12 complexes—to downstream effector pathways in NK cells, T cells, macrophages, osteoclasts, and keratinocytes [PMID:10426994, PMID:19251634, PMID:19332875, PMID:25002577, PMID:20484116]. Its cytoplasmic YINM motif simultaneously recruits the p85 subunit of PI3K and a Grb2–Vav1 signaling intermediate; both interactions are required for full calcium flux, PI3K–Akt activation, Vav1-dependent cytoskeletal polarization at the immunological synapse, and NK cell cytotoxicity [PMID:16582911, PMID:16887996, PMID:12740575]. Post-translational regulation through glycosylation stabilizes NKG2D–DAP10 surface expression, while ligand-induced ubiquitylation of DAP10 drives endocytosis that is essential not for receptor downregulation alone but for productive ERK signaling, degranulation, and IFN-γ production [PMID:21816829, PMID:26508790]. DAP10 transcription is positively regulated by γc-family cytokines and suppressed by TGF-β1 via exclusion of RNA polymerase II from the DAP10 promoter, and DAP10 deficiency in mice causes osteopetrosis due to impaired osteoclastogenesis [PMID:21816829, PMID:19251634].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of DAP10 as the obligate signaling adaptor for NKG2D resolved how this activating receptor, which lacks intrinsic signaling motifs, transduces activating signals in NK and T cells.\",\n      \"evidence\": \"Co-immunoprecipitation, SH2 domain binding assays, and transfection experiments in human NK cells and cell lines\",\n      \"pmids\": [\"10426994\", \"10528161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the NKG2D–DAP10 complex not determined\", \"Upstream kinase phosphorylating the YINM motif not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that transmembrane charge-based interactions confer specificity of adaptor–receptor pairing established that DAP10 and DAP12 define two distinct signaling modules (PI3K vs. ITAM/Syk) that synergize for cytokine production.\",\n      \"evidence\": \"Transmembrane domain swap mutants, reciprocal co-immunoprecipitation, NK cell functional assays\",\n      \"pmids\": [\"11015446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of transmembrane charge pairing unresolved\", \"Whether DAP10 and DAP12 compete for the same receptor pool in vivo unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mutagenesis of the YINM motif showed it is both necessary and sufficient for coupling NKG2D to PI3K, Vav1, and PLC activation and for triggering cytolysis, establishing the minimal signaling unit downstream of DAP10.\",\n      \"evidence\": \"Point mutations in YINM, kinase assays, redirected lysis assays, pathway inhibitors in primary NK cells\",\n      \"pmids\": [\"12740575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single YINM motif simultaneously engages PI3K and Vav1 not resolved\", \"Direct Vav1 binding mechanism unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genetic epistasis using Vav-family knockout mice revealed that Vav1, but not Vav2 or Vav3, is specifically required for DAP10-mediated cytotoxicity, establishing isoform specificity downstream of the adaptor.\",\n      \"evidence\": \"Combinatorial Vav1/2/3 knockout mice, NK cell cytotoxicity assays\",\n      \"pmids\": [\"15365099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Vav1 selectivity over Vav2/3 not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that DAP10 recruits a Grb2–Vav1 intermediate complex in addition to p85-PI3K, and that both arms are required for full signaling, resolved how a single YINM motif activates parallel pathways and controls cytoskeletal polarization at the NK synapse.\",\n      \"evidence\": \"Dominant-negative Grb2, DAP10 mutant analysis, calcium flux, cytotoxicity, confocal imaging of cytoskeletal dynamics in Vav1-KO NK cells\",\n      \"pmids\": [\"16582911\", \"16887996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Grb2 and p85 bind simultaneously or sequentially to the same YINM motif undetermined\", \"Kinase responsible for DAP10 tyrosine phosphorylation still not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"IL-21 was shown to suppress DAP10 promoter activity and surface NKG2D, providing the first evidence that cytokine-mediated transcriptional regulation of DAP10 controls receptor-level NK cell responsiveness.\",\n      \"evidence\": \"DAP10 luciferase reporter, flow cytometry, redirected lysis and degranulation assays in human NK cells\",\n      \"pmids\": [\"16424177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcription factors mediating IL-21's effect on DAP10 promoter not identified\", \"Single-lab finding not independently replicated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"DAP10 was found to associate with receptors beyond NKG2D—MDL-1 in osteoclasts and Ly49H in NK cells—broadening DAP10's role to osteoclastogenesis and antiviral immunity, with DAP10-KO mice exhibiting osteopetrosis.\",\n      \"evidence\": \"DAP10-KO and DAP12-KO mice, co-IP of MDL-1–DAP12–DAP10 trimolecular complex, in vivo MCMV infection model, osteoclastogenesis assays\",\n      \"pmids\": [\"19251634\", \"19332875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DAP10 integrates into trimolecular MDL-1–DAP12 complex structurally unclear\", \"Relative contribution of DAP10 vs. DAP12 signaling in osteoclast differentiation not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Tracking ligand-engaged NKG2D–DAP10 complexes revealed an intracellular recycling pool and lysosomal degradation route, establishing that receptor dynamics regulate sustained signaling capacity.\",\n      \"evidence\": \"Confocal microscopy, subcellular fractionation, live imaging of NK–target conjugates\",\n      \"pmids\": [\"19329438\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular machinery sorting DAP10 between recycling and degradation not identified\", \"Single-lab imaging study\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"DAP10 was shown to function as a co-signaling adaptor for TREM2–DAP12 in macrophages, with SHIP1 acting as a negative regulator by blocking PI3K recruitment, extending DAP10 function to innate immune phagocytes.\",\n      \"evidence\": \"Co-IP, kinase assays, DAP10/DAP12-deficient macrophages, SHIP1 SH2 domain mutants\",\n      \"pmids\": [\"20484116\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DAP10 is required for all TREM2 functions (e.g., microglial phagocytosis) not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Cytokine-mediated regulation of DAP10 was mechanistically dissected: IL-2 enhances DAP10 protein synthesis post-transcriptionally and glycosylation is required for NKG2D stabilization, while TGF-β1 suppresses transcription by excluding RNA Pol II from the DAP10 promoter.\",\n      \"evidence\": \"ChIP for RNA Pol II, metabolic labeling, glycosylation inhibitors, Western blotting, flow cytometry in primary NK cells\",\n      \"pmids\": [\"21816829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of glycosyltransferase(s) modifying DAP10 unknown\", \"Specific TGF-β1-responsive transcription factor mediating Pol II exclusion not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Association of DAP10 with RAGE in keratinocytes demonstrated that DAP10 can switch RAGE signaling from pro-apoptotic (caspase 8) to pro-survival (Akt), revealing a receptor-dependent signaling bifurcation role outside the immune system.\",\n      \"evidence\": \"Co-IP, artificial oligomerization, Akt/caspase 8 assays, DAP10 blocking antibody in keratinocyte cell lines\",\n      \"pmids\": [\"25002577\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of RAGE–DAP10 in skin biology not tested\", \"Single-lab finding without independent confirmation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Ubiquitylation of DAP10 was shown to be required for productive signaling rather than merely receptor downregulation, establishing that endosomal sorting of NKG2D–DAP10 is a prerequisite for ERK activation and effector function.\",\n      \"evidence\": \"Ubiquitylation assays, endocytosis assays, ERK activation, degranulation and IFN-γ secretion assays in primary NK cells\",\n      \"pmids\": [\"26508790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase responsible for DAP10 ubiquitylation not identified\", \"Whether signaling from endosomes requires specific endosomal compartment undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"DAP10 recruits EVL to the cytotoxic synapse via the Grb2-binding site, linking DAP10 directly to F-actin polymerization and establishing a non-canonical effector of the YINM motif.\",\n      \"evidence\": \"Co-IP, confocal imaging of synapse, siRNA knockdown, spreading and cytotoxicity assays in NK cell line\",\n      \"pmids\": [\"31235500\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether EVL and Grb2–Vav1 compete for the same binding site on DAP10 not resolved\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the kinase that phosphorylates the DAP10 YINM motif in physiological settings, the structural basis for simultaneous p85 and Grb2–Vav1 recruitment to a single motif, and the E3 ubiquitin ligase responsible for DAP10 ubiquitylation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream kinase for DAP10 YINM phosphorylation unknown\", \"No crystal structure of DAP10 cytoplasmic domain in complex with dual effectors\", \"E3 ligase for DAP10 ubiquitylation unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 10, 12]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 3, 4, 5, 6, 9, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 5, 11, 13]}\n    ],\n    \"complexes\": [\n      \"NKG2D–DAP10\",\n      \"MDL-1–DAP12–DAP10\",\n      \"TREM2–DAP12–DAP10\"\n    ],\n    \"partners\": [\n      \"KLRK1\",\n      \"PIK3R1\",\n      \"GRB2\",\n      \"VAV1\",\n      \"TYROBP\",\n      \"TREM2\",\n      \"CLEC5A\",\n      \"EVL\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"HCST (DAP10) is a transmembrane adaptor protein that couples activating immunoreceptors—primarily NKG2D, but also Ly49H, MDL-1, TREM2, RAGE, and CD200AR—to intracellular signaling cascades in NK cells, T cells, osteoclasts, and keratinocytes [PMID:10426994, PMID:19251634, PMID:25002577, PMID:33829411]. Its cytoplasmic YINM motif simultaneously recruits the p85 subunit of PI3K and a Grb2–Vav1 complex; both interactions are required for full downstream activation of Akt, ERK, calcium flux, cytoskeletal polarization at the immunological synapse, and cytotoxic granule release [PMID:16582911, PMID:16887996, PMID:26508790]. DAP10 surface expression is regulated transcriptionally by TGF-β1 (which excludes RNA Pol II from the DAP10 promoter) and IL-21, and post-transcriptionally by γc cytokines that promote DAP10 protein synthesis and glycosylation required for NKG2D association and stabilization [PMID:21816829, PMID:16424177]. Ligand-induced ubiquitylation of DAP10 drives receptor endocytosis that is itself required for ERK signaling and effector function, while DAP10-deficient mice develop osteopetrosis and display altered NKT/Treg activation thresholds, revealing roles beyond lymphocyte cytotoxicity [PMID:26508790, PMID:17785813, PMID:19251634].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of DAP10 as a transmembrane adaptor that pairs with NKG2D and recruits PI3K via its YINM motif established the first non-ITAM activation mechanism for NK receptors, answering how NKG2D signals without Syk-family kinases.\",\n      \"evidence\": \"Co-immunoprecipitation, transfection, and PI3K recruitment assays in NK/T cell lines; independent cloning and Grb2 binding demonstration\",\n      \"pmids\": [\"10426994\", \"10528161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of PI3K vs. Grb2 recruitment unresolved\", \"In vivo requirement not yet tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Transmembrane domain swap experiments demonstrated that DAP10 and DAP12 achieve receptor specificity through their transmembrane regions and activate distinct signaling pathways (PI3K vs. ITAM/Syk), resolving how structurally similar adaptors partition among activating receptors.\",\n      \"evidence\": \"TM domain chimeras with NK cytotoxicity and cytokine assays\",\n      \"pmids\": [\"11015446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TM-mediated specificity undefined\", \"Stoichiometry of receptor–adaptor complexes unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mutational dissection of the YINM motif showed it couples NKG2D to PI3K, Vav1, Rho GTPases, and PLC independently of Syk kinases, defining the complete proximal signaling module downstream of DAP10.\",\n      \"evidence\": \"YINM point mutations with NK killing assays and multi-pathway signaling analysis\",\n      \"pmids\": [\"12740575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether both PI3K and Grb2 branches are co-required or redundant was unresolved\", \"Kinase(s) phosphorylating YINM not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Simultaneous binding of both Grb2–Vav1 and p85-PI3K to the same DAP10 YINM motif was shown to be required for full calcium flux and cytotoxicity, resolving the non-redundancy of the two signaling arms and establishing Vav1 as the specific Vav family member mediating DAP10-dependent cytoskeletal polarization and synapse maturation.\",\n      \"evidence\": \"Dominant-negative constructs and YINM point mutations with calcium, Co-IP, and cytotoxicity assays; Vav1/2/3 single and combinatorial KO mice with NK killing assays and cytoskeletal imaging\",\n      \"pmids\": [\"16582911\", \"15365099\", \"16887996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for simultaneous Grb2 and p85 occupancy of one motif unclear\", \"How Vav1 specificity over Vav2/3 is achieved molecularly not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"DAP10 was found to extend beyond NKG2D pairing to form signaling complexes with MDL-1 (via DAP12-dependent recruitment) and Ly49H, and DAP10-deficient mice developed osteopetrosis, broadening DAP10's biological role to osteoclastogenesis and antiviral NK responses.\",\n      \"evidence\": \"Reciprocal Co-IP of MDL-1–DAP12–DAP10 trimolecular complex; DAP10 KO mouse bone histology and osteoclast assays; DAP10/DAP12 single/double KO MCMV infection model with ERK, IFN-γ, and viral titer readouts\",\n      \"pmids\": [\"19251634\", \"19332875\", \"17785813\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DAP10 signals autonomously or only through DAP12-containing complexes with MDL-1 not clarified\", \"Functional significance of DAP10–Ly49D association disputed between labs\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The opposing transcriptional regulation of DAP10 was elucidated: TGF-β1 excludes RNA Pol II from the DAP10 promoter to suppress expression, while γc cytokines promote post-transcriptional DAP10 synthesis and glycosylation required for NKG2D association, explaining how the tumor/infection microenvironment tunes NKG2D–DAP10 surface levels.\",\n      \"evidence\": \"ChIP for RNA Pol II at DAP10 promoter with TGF-β1 treatment; glycosylation inhibitor experiments showing loss of NKG2D–DAP10 co-IP; IL-21 promoter reporter assay\",\n      \"pmids\": [\"21816829\", \"16424177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factors mediating TGF-β1's exclusion of Pol II not identified\", \"Specific glycosylation sites on DAP10 required for NKG2D binding unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that DAP10 pairs with RAGE in keratinocytes to switch RAGE signaling from apoptotic (caspase-8) to pro-survival (Akt) extended DAP10 function beyond hematopoietic cells.\",\n      \"evidence\": \"Co-IP of RAGE–DAP10, Akt phosphorylation and caspase-8 assays, DAP10 blocking antibody in transformed keratinocytes\",\n      \"pmids\": [\"25002577\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of RAGE–DAP10 in vivo not tested\", \"Whether the YINM motif mediates PI3K recruitment in the RAGE context not shown\", \"Single lab observation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Ligand-induced ubiquitylation of DAP10 was shown to drive NKG2D–DAP10 endocytosis, and this endosomal trafficking was required for ERK activation and effector functions (granule release, IFN-γ), revealing that DAP10 signals from endosomes, not only from the plasma membrane.\",\n      \"evidence\": \"Ubiquitylation biochemistry, dominant-negative ubiquitin, confocal endocytosis imaging, ERK and effector function assays in human NK cells\",\n      \"pmids\": [\"26508790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase responsible for DAP10 ubiquitylation not identified\", \"Specific ubiquitin chain type (K48 vs. K63) not determined\", \"Whether endosomal signaling applies to non-NKG2D complexes unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"EVL was identified as a DAP10-recruited actin regulator at the NK synapse, binding through the same Grb2/Vav1 site, and required for F-actin generation and target cell killing, adding a direct cytoskeletal effector to the DAP10 signaling module.\",\n      \"evidence\": \"Co-IP of EVL–DAP10–Grb2–Vav1, siRNA knockdown with synapse imaging and cytotoxicity assays\",\n      \"pmids\": [\"31235500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How EVL, Grb2, and Vav1 are coordinated at a single DAP10 motif structurally unresolved\", \"Whether EVL is required for non-NKG2D DAP10 complexes untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the identity of the E3 ubiquitin ligase that ubiquitylates DAP10, the structural basis for simultaneous occupancy of the YINM motif by PI3K-p85 and Grb2–Vav1–EVL, the kinase(s) that phosphorylate the YINM tyrosine in different receptor contexts, and whether DAP10's role in osteoclastogenesis and RAGE signaling involves the same downstream effectors as in NK cells.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase for DAP10 ubiquitylation unidentified\", \"No structural model of DAP10 signalosome\", \"YINM kinase identity context-dependent and undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 4, 8, 17]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 2, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 10, 19]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [14, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 4, 7, 8, 15, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 8, 17, 23]}\n    ],\n    \"complexes\": [\n      \"NKG2D–DAP10\",\n      \"MDL-1–DAP12–DAP10\",\n      \"TREM2–DAP12–DAP10\"\n    ],\n    \"partners\": [\n      \"KLRK1\",\n      \"PIK3R1\",\n      \"GRB2\",\n      \"VAV1\",\n      \"EVL\",\n      \"TYROBP\",\n      \"TREM2\",\n      \"AGER\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}